TMOD4
gene geneOn this page
Also known as Sk-Tmod
Summary
TMOD4 (tropomodulin 4, HGNC:11874) is a protein-coding gene on chromosome 1q21.3, encoding Tropomodulin-4 (Q9NZQ9). Blocks the elongation and depolymerization of the actin filaments at the pointed end.
Predicted to enable tropomyosin binding activity. Predicted to be involved in actin filament organization; muscle contraction; and myofibril assembly. Located in striated muscle thin filament.
Source: NCBI Gene 29765 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_013353
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11874 |
| Approved symbol | TMOD4 |
| Name | tropomodulin 4 |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Sk-Tmod |
| Ensembl gene | ENSG00000163157 |
| Ensembl biotype | protein_coding |
| OMIM | 605834 |
| Entrez | 29765 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 10 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000295314, ENST00000441701, ENST00000463543, ENST00000466891, ENST00000488488, ENST00000601585, ENST00000945625, ENST00000945626, ENST00000945627, ENST00000945628, ENST00000945629, ENST00000945630, ENST00000945631
RefSeq mRNA: 1 — MANE Select: NM_013353
NM_013353
CCDS: CCDS988
Canonical transcript exons
ENST00000295314 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001592965 | 151174391 | 151174547 |
| ENSE00001824229 | 151175924 | 151175981 |
| ENSE00003231271 | 151174753 | 151174917 |
| ENSE00003508053 | 151169987 | 151170103 |
| ENSE00003508763 | 151171633 | 151171763 |
| ENSE00003515372 | 151172268 | 151172357 |
| ENSE00003526441 | 151173499 | 151173615 |
| ENSE00003627787 | 151170519 | 151170663 |
| ENSE00003650418 | 151171433 | 151171540 |
| ENSE00003687002 | 151170920 | 151171063 |
Expression profiles
Bgee: expression breadth ubiquitous, 176 present calls, max score 99.51.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.4866 / max 578.8173, expressed in 39 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14413 | 1.2652 | 36 |
| 14414 | 0.2214 | 26 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| vastus lateralis | UBERON:0001379 | 99.51 | gold quality |
| quadriceps femoris | UBERON:0001377 | 99.50 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 99.41 | gold quality |
| tibialis anterior | UBERON:0001385 | 99.28 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 99.26 | gold quality |
| biceps brachii | UBERON:0001507 | 99.25 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 99.25 | gold quality |
| gastrocnemius | UBERON:0001388 | 99.23 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 99.15 | gold quality |
| deltoid | UBERON:0001476 | 99.09 | gold quality |
| muscle organ | UBERON:0001630 | 98.26 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 98.26 | gold quality |
| muscle of leg | UBERON:0001383 | 97.97 | gold quality |
| body of tongue | UBERON:0011876 | 97.05 | gold quality |
| muscle tissue | UBERON:0002385 | 94.22 | gold quality |
| tongue | UBERON:0001723 | 88.22 | gold quality |
| granulocyte | CL:0000094 | 84.13 | gold quality |
| mucosa of stomach | UBERON:0001199 | 80.56 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 76.98 | gold quality |
| right uterine tube | UBERON:0001302 | 76.48 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 75.96 | gold quality |
| monocyte | CL:0000576 | 75.91 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 75.70 | gold quality |
| lower esophagus | UBERON:0013473 | 75.64 | gold quality |
| superior surface of tongue | UBERON:0007371 | 75.52 | gold quality |
| leukocyte | CL:0000738 | 75.44 | gold quality |
| spleen | UBERON:0002106 | 75.37 | gold quality |
| minor salivary gland | UBERON:0001830 | 74.68 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 74.59 | gold quality |
| vermiform appendix | UBERON:0001154 | 73.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.48 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmod4 | ENSDARG00000020890 |
| mus_musculus | Tmod4 | ENSMUSG00000005628 |
| rattus_norvegicus | Tmod4 | ENSRNOG00000021088 |
| drosophila_melanogaster | tmod | FBGN0082582 |
| caenorhabditis_elegans | unc-94 | WBGENE00006823 |
Paralogs (6): TMOD2 (ENSG00000128872), TMOD1 (ENSG00000136842), TMOD3 (ENSG00000138594), LMOD3 (ENSG00000163380), LMOD1 (ENSG00000163431), LMOD2 (ENSG00000170807)
Protein
Protein identifiers
Tropomodulin-4 — Q9NZQ9 (reviewed: Q9NZQ9)
Alternative names: Skeletal muscle tropomodulin
All UniProt accessions (4): Q9NZQ9, K7EQW4, K7ES04, Q5JR82
UniProt curated annotations — full annotation on UniProt →
Function. Blocks the elongation and depolymerization of the actin filaments at the pointed end. The Tmod/TM complex contributes to the formation of the short actin protofilament, which in turn defines the geometry of the membrane skeleton.
Subunit / interactions. Binds to the N-terminus of tropomyosin and to actin.
Subcellular location. Cytoplasm. Cytoskeleton.
Tissue specificity. Highly expressed in skeletal muscle.
Similarity. Belongs to the tropomodulin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NZQ9-1 | 1 | yes |
| Q9NZQ9-2 | 2 |
RefSeq proteins (1): NP_037485* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004934 | TMOD | Family |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
Pfam: PF03250
UniProt features (6 total): sequence conflict 2, chain 1, region of interest 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NZQ9-F1 | 86.28 | 0.51 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-390522 | Striated Muscle Contraction |
MSigDB gene sets: 118 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY, GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION, SP3_Q3, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION, GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION, AP4_Q6, GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, CAGCTG_AP4_Q5, GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, EVI1_05, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE
GO Biological Process (4): muscle contraction (GO:0006936), actin filament organization (GO:0007015), myofibril assembly (GO:0030239), pointed-end actin filament capping (GO:0051694)
GO Molecular Function (3): actin binding (GO:0003779), tropomyosin binding (GO:0005523), protein binding (GO:0005515)
GO Cellular Component (4): cytoskeleton (GO:0005856), striated muscle thin filament (GO:0005865), myofibril (GO:0030016), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Muscle contraction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| supramolecular fiber organization | 2 |
| cytoskeletal protein binding | 2 |
| muscle system process | 1 |
| actin cytoskeleton organization | 1 |
| cellular component assembly involved in morphogenesis | 1 |
| actomyosin structure organization | 1 |
| striated muscle cell development | 1 |
| membraneless organelle assembly | 1 |
| actin filament capping | 1 |
| binding | 1 |
| intracellular membraneless organelle | 1 |
| actin cytoskeleton | 1 |
| sarcomere | 1 |
| myofilament | 1 |
| contractile muscle fiber | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1084 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMOD4 | CARMIL1 | Q5VZK9 | 972 |
| TMOD4 | ADD1 | P35611 | 970 |
| TMOD4 | CAPZA3 | Q96KX2 | 963 |
| TMOD4 | ADD2 | P35612 | 953 |
| TMOD4 | ADD3 | Q9UEY8 | 947 |
| TMOD4 | NEB | P20929 | 931 |
| TMOD4 | CARMIL2 | Q6F5E8 | 899 |
| TMOD4 | CAPZA2 | P47755 | 888 |
| TMOD4 | CAPZA1 | P52907 | 885 |
| TMOD4 | DMTN | Q08495 | 883 |
| TMOD4 | EPB41 | P11171 | 820 |
| TMOD4 | MYPN | Q86TC9 | 810 |
| TMOD4 | SCIN | Q9Y6U3 | 767 |
| TMOD4 | GSN | P06396 | 750 |
| TMOD4 | TWF2 | Q6IBS0 | 733 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TXN2 | TMOD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMOD4 | PCNA | psi-mi:“MI:0915”(physical association) | 0.370 |
| IDH1 | TMOD4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TMOD4 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| TMOD4 | FECH | psi-mi:“MI:0914”(association) | 0.350 |
| CDC37L1 | EL52 | psi-mi:“MI:0914”(association) | 0.350 |
| HSP90AB1 | EL52 | psi-mi:“MI:0914”(association) | 0.350 |
| TTC4 | EL52 | psi-mi:“MI:0914”(association) | 0.350 |
| TXN2 | TMOD4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (47): LRRFIP1 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), FECH (Affinity Capture-MS), LRRFIP2 (Affinity Capture-MS), FLII (Affinity Capture-MS), MYO5A (Affinity Capture-MS), ALAS1 (Affinity Capture-MS), CSRP2BP (Affinity Capture-MS), GIT1 (Affinity Capture-MS), NELFA (Affinity Capture-MS), HSP90AA4P (Affinity Capture-MS), MYO5C (Affinity Capture-MS), GIT2 (Affinity Capture-MS), ACAD11 (Affinity Capture-MS), MYO9A (Affinity Capture-MS)
ESM2 similar proteins: A0JNC0, A1A5Q0, A2VE39, A4IHS2, D2HRF1, E1BTG2, O08808, O14730, O35226, O60870, O95801, P28289, P42898, P49813, P70566, P70567, Q0VC48, Q13576, Q1JQD4, Q1RMT7, Q2M146, Q3UQ44, Q58DA0, Q5BLF0, Q5EA11, Q5I598, Q5R981, Q5U2Z5, Q60HE5, Q6GNS3, Q6P2Z6, Q6P5Q4, Q6TH47, Q7T0W1, Q7ZXX9, Q803R5, Q8K339, Q8N1G2, Q8R3H9, Q8R424
Diamond homologs: A0A0G2K0D3, A0JNC0, A1A5Q0, E1BTG2, E7F7X0, E9QA62, O01479, P28289, P29536, P49813, P70566, P70567, Q0VAK6, Q0VC48, Q3UHZ5, Q6P5Q4, Q8BVA4, Q9JHJ0, Q9JKK7, Q9JLH8, Q9NYL9, Q9NZQ9, Q9NZR1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 55 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1464 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:151170517:A:AC | donor_gain | 1.0000 |
| 1:151170518:C:CC | donor_gain | 1.0000 |
| 1:151170662:CG:C | acceptor_gain | 1.0000 |
| 1:151170664:C:CC | acceptor_gain | 1.0000 |
| 1:151172263:CTCA:C | donor_gain | 1.0000 |
| 1:151172266:A:AC | donor_gain | 1.0000 |
| 1:151172267:C:CA | donor_gain | 1.0000 |
| 1:151172267:CTG:C | donor_gain | 1.0000 |
| 1:151173494:CCCA:C | donor_loss | 1.0000 |
| 1:151173616:C:CC | acceptor_gain | 1.0000 |
| 1:151174389:AC:A | donor_gain | 1.0000 |
| 1:151174390:CC:C | donor_gain | 1.0000 |
| 1:151174390:CCCTT:C | donor_gain | 1.0000 |
| 1:151174927:A:C | acceptor_gain | 1.0000 |
| 1:151170104:C:CG | acceptor_loss | 0.9900 |
| 1:151170105:T:G | acceptor_loss | 0.9900 |
| 1:151170510:GTTAC:G | donor_loss | 0.9900 |
| 1:151170511:TTACT:T | donor_loss | 0.9900 |
| 1:151170512:TACT:T | donor_loss | 0.9900 |
| 1:151170513:AC:A | donor_loss | 0.9900 |
| 1:151170514:C:CA | donor_loss | 0.9900 |
| 1:151170515:T:TG | donor_loss | 0.9900 |
| 1:151170516:CA:C | donor_loss | 0.9900 |
| 1:151170517:ACGTA:A | donor_loss | 0.9900 |
| 1:151170518:C:A | donor_loss | 0.9900 |
| 1:151170518:CG:C | donor_gain | 0.9900 |
| 1:151170518:CGT:C | donor_gain | 0.9900 |
| 1:151170518:CGTA:C | donor_gain | 0.9900 |
| 1:151170659:TGGCG:T | acceptor_gain | 0.9900 |
| 1:151170660:GGCG:G | acceptor_gain | 0.9900 |
AlphaMissense
2291 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:151171004:G:C | N262K | 0.999 |
| 1:151171004:G:T | N262K | 0.999 |
| 1:151171009:A:G | S261P | 0.998 |
| 1:151170577:A:C | F319L | 0.997 |
| 1:151170577:A:T | F319L | 0.997 |
| 1:151170578:A:G | F319S | 0.997 |
| 1:151170579:A:G | F319L | 0.997 |
| 1:151170936:A:G | L285P | 0.997 |
| 1:151171005:T:A | N262I | 0.997 |
| 1:151171008:G:A | S261F | 0.997 |
| 1:151171020:A:G | L257P | 0.997 |
| 1:151171642:A:C | N203K | 0.997 |
| 1:151171642:A:T | N203K | 0.997 |
| 1:151170543:C:G | A331P | 0.996 |
| 1:151170552:C:G | A328P | 0.996 |
| 1:151171006:T:A | N262Y | 0.996 |
| 1:151171011:T:A | E260V | 0.996 |
| 1:151171016:G:C | N258K | 0.996 |
| 1:151171016:G:T | N258K | 0.996 |
| 1:151171437:G:T | A241D | 0.996 |
| 1:151170627:C:G | A303P | 0.995 |
| 1:151170637:C:A | E299D | 0.995 |
| 1:151170637:C:G | E299D | 0.995 |
| 1:151170920:C:A | Q290H | 0.995 |
| 1:151170920:C:G | Q290H | 0.995 |
| 1:151171047:A:G | L248S | 0.995 |
| 1:151171451:A:C | S236R | 0.995 |
| 1:151171451:A:T | S236R | 0.995 |
| 1:151171453:T:G | S236R | 0.995 |
| 1:151171639:A:C | N204K | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000141052 (1:151175756 G>A,C), RS1000857135 (1:151172158 T>C,G), RS1001034876 (1:151177837 T>C), RS1001373081 (1:151171734 C>G), RS1001465731 (1:151170622 G>A,T), RS1001819853 (1:151176821 T>C), RS1002218154 (1:151176962 A>G), RS1002322921 (1:151176329 T>A), RS1002355092 (1:151172556 G>A), RS1002468238 (1:151172282 G>A), RS1002942544 (1:151177905 A>G), RS1003376367 (1:151173797 G>A), RS1003473429 (1:151173412 T>C), RS1003834085 (1:151172852 C>T), RS1004882199 (1:151173923 A>T)
Disease associations
OMIM: gene MIM:605834 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009879_5 | Coronary artery disease | 1.000000e-28 |
| GCST010476_5 | Myocardial infarction | 9.000000e-25 |
| GCST010477_8 | Hypertension | 5.000000e-07 |
| GCST010478_8 | Chronic kidney disease | 1.000000e-07 |
| GCST010836_6 | Ischemic stroke | 9.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Aspirin | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Silicon Dioxide | increases expression | 1 |
| Testosterone | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): chronic kidney disease, coronary artery disorder, hypertensive disorder, myocardial infarction